Potential harms associated with 4-aminoquinoline treatment

Hydroxychloroquine and chloroquine are currently being evaluated as treatment against COVID-19. These drugs are associated with some potential harms, including QTc-interval prolongation, hypoglycaemia, severe skin reactions and psychiatric effects. Use of hydroxychloroquine or chloroquine should be...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Läkartidningen 2020-04, Vol.117
1. Verfasser:	Svensson, Markus
Format:	Artikel
Sprache:	swe
Schlagworte:	Aminoquinolines - adverse effects Aminoquinolines - therapeutic use Antimalarials - adverse effects Antiviral Agents - adverse effects Betacoronavirus Chloroquine - adverse effects Coronavirus Infections - drug therapy COVID-19 Humans Hydroxychloroquine - adverse effects Pandemics Pneumonia, Viral - drug therapy SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Hydroxychloroquine and chloroquine are currently being evaluated as treatment against COVID-19. These drugs are associated with some potential harms, including QTc-interval prolongation, hypoglycaemia, severe skin reactions and psychiatric effects. Use of hydroxychloroquine or chloroquine should be reserved to current indications or clinical trials, as recommended by several governmental medical products agencies.
ISSN:	1652-7518